Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Zilina

51 clinical trials in Zilina, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Zilina at a glance
51
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

51 trials in Zilina

Open in trial search
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:SlovakiaSlovakia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Zilina

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular disease treatments, including studies evaluating medications for hypertriglyceridemia and atherosclerosis prevention.

  • Heart failure management
  • Lipid-lowering therapies
  • Stroke prevention

Multiple studies are investigating novel approaches to reduce major cardiovascular events and improve patient outcomes.

02 Respiratory Medicine

Comprehensive research into asthma treatments, particularly focusing on patients with uncontrolled symptoms despite current therapy.

  • Severe asthma management
  • New inhaler formulations
  • Exacerbation prevention

Studies aim to evaluate innovative therapeutic combinations and delivery systems.

03 Ophthalmology Studies

Advanced research in macular degeneration treatments, including both wet AMD and geographic atrophy.

  • Novel therapeutic agents
  • Comparative treatment studies
  • Visual acuity preservation

Trials focus on developing effective treatments to prevent vision loss and disease progression.

04 Metabolic Disorders

Studies examining treatments for Type 2 Diabetes and related metabolic conditions.

  • Diabetes management
  • Cardiovascular outcomes
  • Diabetic retinopathy

Research aims to improve glycemic control and reduce diabetes-related complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).